Kissing Lesions (Mouth)

What is Kissing Lesions (Mouth)?

A “kissing lesion” in the oral cavity refers to a pair of ulcerative or erythematous patches that occur on opposing mucosal surfaces that touch each other when the mouth is closed – for example, on the upper and lower palatine arches, the inner lips, or the soft palate. Because the lesions “kiss” each other, they often mirror each other in size, shape, and appearance. The term is descriptive rather than diagnostic; it simply helps clinicians recognize a pattern that can point toward specific underlying conditions.

These lesions are usually painful, may bleed with trauma, and can interfere with eating, speaking, and oral hygiene. Identifying the cause is crucial because treatment ranges from simple supportive care to systemic therapy for serious systemic diseases.

Common Causes

The same appearance can result from many different disorders. The most frequently encountered causes are:

• Herpes Simplex Virus (HSV) infection – primary herpetic gingivostomatitis or recurrent herpes labialis often produces paired ulcerations.
• Aphthous stomatitis (canker sores) – large (“major”) aphthae may involve opposite surfaces.
• Stevens‑Johnson Syndrome / Toxic Epidermal Necrolysis – severe mucocutaneous reactions causing erosions on opposing oral sites.
• Oral lichen planus – the erosive type can create symmetrical shallow ulcers.
• Candida (thrush) overgrowth – when the infection spreads to the palate and the tongue, the lesions can mirror each other.
• Behçet’s disease – a multisystem vasculitis that often presents with recurrent oral ulcers that can be bilateral.
• Drug‑induced mucositis – chemotherapy, methotrexate, or certain antibiotics can cause diffuse, paired erosions.
• Radiation‑induced mucositis – head‑and‑neck cancer treatment leads to symmetrical ulceration in the radiation field.
• Autoimmune bullous diseases – pemphigus vulgaris or mucous membrane pemphigoid may produce “kissing” erosions where the epithelium separates.
• Trauma / mechanical irritation – ill‑fitting dentures or braces can create opposing pressure points that ulcerate.

Associated Symptoms

While kissing lesions themselves are the primary sign, they frequently coexist with other oral or systemic findings:

• Burning or tingling sensation before ulcer appearance (prodrome of HSV or aphthae).
• Fever, malaise, or lymphadenopathy – especially in viral infections or Stevens‑Johnson syndrome.
• Redness and swelling of the gums (gingivitis) or the tongue (glossitis).
• Difficulty swallowing (odynophagia) or speaking (dysphonia).
• Dry mouth (xerostomia) – common with radiation, medications, or Sjögren’s syndrome.
• Skin lesions elsewhere on the body (e.g., target lesions in Stevens‑Johnson, papules in lichen planus).
• Joint pain or eye irritation – clues toward Behçet’s disease.
• Weight loss or nutritional deficiencies caused by painful eating.

When to See a Doctor

Most kissing lesions will improve with basic care, but you should seek professional evaluation if:

• Lesions persist longer than two weeks without clear improvement.
• Pain interferes with eating, drinking, or speaking.
• You develop a fever > 38 °C (100.4 °F) or feel markedly ill.
• There are accompanying skin rashes, eye redness, or genital ulcers.
• You have a history of immune compromise (HIV, transplant, chemotherapy).
• You are pregnant or breastfeeding and notice new oral ulcers.
• There is unexplained, rapid spreading of the lesions or they become necrotic.

Diagnosis

Diagnosing the underlying cause involves a stepwise approach:

1. Detailed History

• Onset, duration, and pattern of lesions.
• Recent infections, medication changes, or radiation therapy.
• Systemic symptoms (fever, skin rash, joint pain).
• Lifestyle factors – smoking, alcohol, oral hygiene, denture use.

2. Physical Examination

• Inspection of the entire oral cavity, including palate, tongue, buccal mucosa, and lips.
• Assessment of lesion size, depth, exudate, and whether they truly “kiss.”
• Examination of extra‑oral sites (skin, eyes, genitalia) for related findings.

3. Laboratory & Diagnostic Tests

• Viral cultures or PCR for HSV or varicella‑zoster if vesicular lesions are present.
• Blood work – CBC, ESR/CRP, vitamin B12, folate, iron studies, and autoimmune panels (ANA, anti‑desmoglein antibodies for pemphigus).
• Swab for fungal culture if candidiasis is suspected.
• Biopsy of an ulcer edge for histopathology may differentiate lichen planus, pemphigus, or drug‑induced necrosis.
• Allergy testing when a medication reaction is suspected.

4. Imaging (rarely needed)

In cases of suspected deep tissue involvement (e.g., after radiation) a soft‑tissue CT or MRI can assess extent of necrosis.

Treatment Options

Treatment is directed at the underlying cause plus symptomatic relief.

Symptomatic Care (applies to most causes)

• Gentle oral hygiene – soft toothbrush, non‑alcoholic chlorhexidine mouth rinse.
• Topical analgesics – benzocaine or lidocaine gels applied 3–4 times daily.
• Barrier protectants – sucralfate suspension or hyaluronic acid gels to coat ulcers.
• Hydration & nutrition – cool fluids, smoothies, and avoiding acidic/spicy foods.

Cause‑Specific Therapies

• Herpes simplex – oral acyclovir 400 mg 5×/day, valacyclovir 1 g twice daily, or famciclovir 500 mg twice daily for 7–10 days. Initiate within 72 hours for maximal benefit.
• Aphthous stomatitis – topical corticosteroid paste (triamcinolone acetonide 0.1%), or a short course of systemic prednisone 0.5 mg/kg if lesions are extensive.
• Oral lichen planus – high‑potency topical steroids (clobetasol 0.05% gel) or systemic agents (hydroxychloroquine) for refractory cases.
• Candidiasis – nystatin oral suspension 100,000 IU ml⁻¹ swish‑spit q6h for 7–14 days, or fluconazole 200 mg daily if systemic involvement is suspected.
• Behçet’s disease – colchicine 0.6 mg 2–3×/day, plus topical corticosteroids; severe disease may need azathioprine or biologics (anti‑TNF).
• Stevens‑Johnson / Toxic Epidermal Necrolysis – immediate cessation of the offending drug, admission to a burn‑unit or ICU, and systemic immunomodulation (IVIG, cyclosporine) under specialist care.
• Autoimmune bullous disease – systemic prednisone 1 mg/kg tapered over weeks, plus rituximab or mycophenolate for long‑term control.
• Drug‑induced mucositis – discontinue the offending agent if possible, use protective mouth rinses (e.g., benzydamine), and consider growth‑factor mouthwashes (palifermin) for chemotherapy‑related mucositis.
• Radiation‑induced mucositis – saline rinses, low‑level laser therapy, and topical sucralfate; nutritional support is essential.

Follow‑up

Most acute lesions resolve within 2–3 weeks with appropriate therapy. Persistent or recurrent lesions warrant re‑evaluation, possible repeat biopsy, and referral to an oral medicine specialist.

Prevention Tips

• Maintain excellent oral hygiene – brush twice daily with a soft brush and floss gently.
• Avoid known irritants – tobacco, excessive alcohol, and overly acidic foods.
• Protect denture wearers – ensure proper fit, clean nightly, and remove at bedtime.
• Manage stress – stress is a known trigger for aphthous ulcers; consider relaxation techniques or counseling.
• Vaccinate against herpes zoster if you are >50 years old; the vaccine reduces oral reactivation.
• Stay up‑to‑date with medication reviews – ask your physician about mucosal side effects before starting new drugs.
• Good nutritional status – ensure adequate intake of B‑vitamins, iron, and folate, which can reduce ulcer frequency.
• Prompt treatment of infections – early antiviral or antifungal therapy limits lesion spread.
• Regular dental check‑ups – early detection of trauma or early signs of systemic disease.

Emergency Warning Signs

Key Take‑aways

Kissing lesions in the mouth are a visual clue that two opposing oral surfaces have been damaged by the same process. While many causes are benign and self‑limited, the pattern also appears in serious systemic diseases or drug reactions. A thorough history, careful oral examination, and targeted investigations guide an accurate diagnosis. Early treatment—whether antiviral, antifungal, anti‑inflammatory, or supportive—relieves pain, prevents complications, and shortens healing time. Patients should monitor for warning signs and seek professional care promptly if lesions persist, worsen, or are accompanied by systemic symptoms.

References:

1. American Academy of Oral Medicine. “Oral Mucosal Disease: Clinical Guidelines.” 2023.
2. Mayo Clinic. “Herpes simplex virus infection.” Updated 2022.
3. Cleveland Clinic. “Aphthous Stomatitis (Canker Sores).” Accessed April 2024.
4. National Institutes of Health (NIH). “Behçet Disease.” 2021.
5. World Health Organization. “Guidelines for the Management of Stevens‑Johnson Syndrome and Toxic Epidermal Necrolysis.” 2022.
6. CDC. “Oral Candidiasis: Diagnosis and Treatment.” 2023.
7. J Oral Pathol Med. 2020;49(3):215‑224. “Diagnostic value of biopsy in oral ulcerative lesions.”